+34 679 490 537info@nanbiosis.com

Welcome to Nanbiosis – ICTS

NANBIOSIS is one of the 29 ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Council for Science Policy, Technology and Innovation (MINECO).  NANBIOSIS provides complete services for the production and characterization of nanomaterials, biomaterials and systems in biomedicine. This ICTS is integrated by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Jesus Uson Minimally Invasive Surgery Centre (JUMISC).

Platform units

NANBIOSIS is organized in five platforms distributed in Spain: Alava, Badajoz, Barcelona, Cáceres, Madrid, Valencia and Zaragoza. This infrastructure provides high technological resources and high qualified personal, and offers open services to the scientific community.

News

20 Nov

Design of parenteral MNP-loaded PLGA nanoparticles by a low-energy emulsification approach as theragnostic platforms for intravenous or intratumoral administration

Encapsulation of magnetic nanoparticles (MNP) into PLGA nanoparticles has been achieved by nano-emulsion templating using for the first time both, a low-energy emulsification method as well as biocompatible components accepted for pharmaceuticals intended for human use. The incorporation of MNP by nano-emulsion templating method proposed in this work has been investigated in two different systems [...]

20 Nov

Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery

Unit 1 of NANBIOSIS, Protein Production Platform (PPP) and the  Nanobiotechnology research group of CIBER-BBN in collaboration with the Universidade Estadual de Campinas and the Universidade de São Paulo have recently published, in the European Journal of Pharmaceutical Sciences, the results of the research devoted to the improvement of protein-only based nanoconjugates for gene therapy. The evaluated gene-therapy vehicle prototype  displayed a similar transfection efficiency to that of the [...]

17 Nov

Unit 13 of NANBIOSIS participates in a new European project that will boost the Organ-on-Chip technology

The research group coordinating NANBIOSIS Unit 13 is the Spanish group of the European project ORCHID (Organ-On-Chip In Development). The scientists  of Engineering Research Institute (I3A) and CIBER-BBN, Luis Fernández and Iñaki Ochoa, will work on this project whose objective is to accelerate the social and economic impact of the technology known as Organ-on-Chip. This [...]

Next Events

SEE ALL EVENTS

About Nanbiosis

1. PLATFORM Biomolecules Production 2. PLATFORM Biomaterials and Nanomaterials Production 3. PLATFORM Tissue, Biomaterial and Surface Characterization 4. PLATFORM Bioimaging 5. PLATFORM High Performance Computing

Nanbiosis: Catalog 2015

The Spanish Strategy for Science, Technology and Innovation 2013-2020, adopted by the Council of Ministers on February 1st, 2013, includes the update of the “National Scientific and Technological Infrastructure Map (ICTS)” for the period 2013-2016 and 2016-2020.

 

The so-called singular scientific and technical infrastructures (ICTS) are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas ranging from the life sciences to astrophysics or engineering, distributed throughout the Spanish territory.

NANBIOSIS has been recognized by the Spanish Government as one of these 29 UNIQUE existing ICTS, which are OPEN to competitive access to users of the whole research community in the public and private sector.

FAQ

What is NANBIOSIS?

It is one of the 29 UNIQUE ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Government (MINECO) which is managed by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Center for Minimally Invasive Surgery Jesus Uson (JUMISC).
NANBIOSIS coordinates 27 complementary services under a single contact point model.

Which kind of services offers the platform units?

NANBIOSIS provides a complete service that includes the design and production of biomaterials and nanomaterials and their nanoconjugates, and the characterization of these bio-/nanomaterials, tissues and medicals devices from a physic-chemical, functional, toxicological and biological (including preclinical validation) point of view, focused also on biomedical applications such as: IVDs, biosensors, regenerative medicine, drug delivery, therapeutic agents or MRI contrast agents and medical devices. A Unit dedicated to high performance computing is also included for those technological applications with large scale computational demand.

Who can use these services?

NANABIOSIS is OPEN to users of the whole research community in the public and private sector.
Order request Access protocolSurvey

Our figures

0

Units

0

Scientists linked to ICTS

0

Projects since 2008

0

Services since 2008

0

Publications since 2008

0

M€ investment

Nanbiosis